Cardiology for gynecologists--a minireview
Karin Schenck-Gustafsson1, Margaret Rees
1Department of Medicine, Cardiac Unit and Centre for Gender Medicine, Karolinska Institutet, Solna, Sweden. karin.schenck-gustafsson@ki.se
Maturitas
|June 4, 2013
Summary
Cardiovascular disease (CVD) is a leading cause of death in women, often presenting with atypical symptoms. Early awareness and management of risk factors by gynecologists are crucial for prevention.
Area of Science:
- Cardiology
- Women's Health
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is the leading cause of death globally among women, yet awareness remains low.
- Myocardial infarction (MI) in women often occurs a decade later than in men and may present with atypical symptoms like dyspnea, differing from the typical chest pain.
- A significant proportion of women experience myocardial infarction with normal coronary angiography, potentially due to underlying microvascular disease or coronary spasm, conditions now recognized as having similar prognoses to obstructive disease.
Purpose of the Study:
- To highlight the low awareness of cardiovascular disease (CVD) in women.
- To underscore the unique risk factors and atypical presentations of CVD in women.
- To emphasize the critical role of gynecologists in early CVD detection and prevention strategies.
Main Methods:
- Review of current literature on cardiovascular disease epidemiology, risk factors, and clinical presentation in women.
- Analysis of gender-specific differences in myocardial infarction (MI) presentation and diagnostic findings.
- Examination of unique female risk factors including pre-eclampsia, gestational diabetes, and polycystic ovary syndrome (PCOS).
Main Results:
- Myocardial infarction (MI) occurs approximately 10 years later in women than men, with atypical symptoms such as dyspnea being more common than chest pain.
- Women are more likely to have MI with normal coronary angiography, linked to microvascular disease or coronary spasm.
- Specific risk factors for women include a history of pre-eclampsia, gestational hypertension or diabetes, and polycystic ovary syndrome (PCOS). Atrial fibrillation poses a greater stroke risk for women.
Conclusions:
- Cardiovascular disease (CVD) presents unique challenges in women, necessitating increased awareness and tailored screening.
- Gynecologists are uniquely positioned to identify cardiovascular risks in women from an earlier age.
- Preventive measures, including lifestyle modifications and management of risk factors, can significantly reduce CVD mortality in women, with 6 out of 10 deaths being preventable.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
